Business
Cardiff Lexington Corporation Announces Upgrade to OTCQX Best Market
Cardiff Lexington Corporation Announces Upgrade to OTCQX Best Market.
About this update from Cardiff Lexington Corporation
[{"type":"text","content":"\r\n\r\n \r\n \r\n Cardiff Lexington Corporation Announces Upgrade to OTCQX Best Market\r\n \r\n \r\n\r\n\r\nCardiff Lexington Corporation Announces Upgrade to OTCQX Best Market\r\n\r\n\r\n\r\n\r\n\r\nLEXINGTON, KY / ACCESS Newswire / April 9, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) (\"Cardiff Lexington\" or the \"Company\"), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that its common stock has been approved to trade on the OTCQX® Best Market, the highest-level market of the OTC Markets, effective at the commencement of trading on Thursday, April 9th, 2026. The Company will continue to trade under the symbol \"CDIX\".\r\n The OTCQX Best Market is designed for established, investor-focused companies and requires high financial standards, strong corporate governance, and compliance with applicable securities laws.\r\n Strategic Positioning and Market Advancement\r\n Upgrading to OTCQX from the OTCQB® Venture Market reflects Cardiff Lexington's continued commitment to enhanced transparency and maintaining the highest governance and financial reporting standards available to companies trading on the OTC Markets.\r\n \"We view our upgrade to the OTCQX Best Market as a meaningful milestone in Cardiff Lexington's evolution as a disciplined, growth-oriented healthcare platform,\" said Alex H. Cunningham, Chief Executive Officer of Cardiff Lexington Corporation. \"This transition strengthens our visibility within the institutional investor community and reinforces our commitment to building a scalable, high-margin healthcare enterprise with a clear path toward a national exchange listing. Listing on a national exchange would significantly enhance access to working capital to support increased patient volume and procedural throughput without relying on higher-cost financing structures and accelerate our accounts receivable conversion cycles. We look forward to leveraging this enhanced OTCQX visibility alongside our high-margin operating model to drive sustainable revenue growth, expand margins, and enhance long-term shareholder value.\"\r\n Demonstrated Financial Performance and Operating Leverage\r\n Cardiff Lexington has demonstrated consistent financial growth and operating performance driven by its focused healthcare platform str...